Pooled results of six clinical trials proved that berberine markedly lowered the CRP levels in patients with T2DM (SMD = −2.13, 95% CI (−2.98, −1.28), P < 0.05, I2 = 96%, 95% CI (0.94, 0.97)). This evidence concerns the gene CRP and type 2 diabetes mellitus.